imidacloprid has been researched along with Cirrhosis, Liver in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bing, Q; Deng, N; Han, B; Jiang, H; Li, S; Liu, Y; Lv, Y; Wang, X; Wu, P; Yang, Q; Zhang, Z | 1 |
| Bing, Q; Han, B; Li, S; Lv, Y; Lv, Z; Wang, X; Xue, J; Yang, Q; Zhang, Z | 1 |
2 other study(ies) available for imidacloprid and Cirrhosis, Liver
| Article | Year |
|---|---|
Inhibition of the Nrf2 signaling pathway involved in imidacloprid-induced liver fibrosis in Coturnix japonica.
Topics: Animals; Coturnix; Liver; Liver Cirrhosis; Neonicotinoids; NF-E2-Related Factor 2; Nitro Compounds; Oxidative Stress; Quail; Signal Transduction | 2022 |
Imidacloprid-induced liver fibrosis in quails via activation of the TGF-β1/Smad pathway.
Topics: Animals; Liver Cirrhosis; Neonicotinoids; Nitro Compounds; Quail; Transforming Growth Factor beta1 | 2020 |